Article
Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Mar 2016
Hesselink A T, Sahli R, Berkhof J, Snijders P J F, van der Salm M L, Agard D, Bleeker M C G, Heideman D A M
Abstract excerpt
BACKGROUND: Anyplex™ II HPV HR Detection (Seegene, Seoul, Korea) is a multiplex real-time PCR using tagging oligonucleotide cleavage and extension (TOCE) technology for simultaneous detection and genotyping of 14 high-risk (HR) HPV types, including HPV16 and HPV18. OBJECTIVES: To evaluate whether the clinical performance and reproducibility of Anyplex™ II HPV HR Detection meet the international consensus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
